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Abstract
Background: Most smokers do not receive comprehensive, evidence-based treatment for tobacco use that
includes intensive behavioral counseling along with pharmacotherapy. Further, the use of proven, tobacco
treatments is lower among minorities than among Whites. The primary objectives of this study are to: (1) Assess
the effect of a proactive care intervention (PRO) on population-level smoking abstinence rates (i.e., abstinence
among all smokers including those who use and do not utilize treatment) and on utilization of tobacco treatment
compared to reactive/usual care (UC) among a diverse population of smokers, (2) Compare the effect of PRO on
population-level smoking abstinence rates and utilization of tobacco treatments between African American and
White smokers, and (3) Determine the cost-effectiveness of the proactive care intervention.
Methods/Design: This prospective randomized controlled trial identifies a population-based sample of current
smokers from the Department of Veterans Affairs (VA) electronic medical record health factor dataset. The proactive
care intervention combines: (1) proactive outreach and (2) offer of choice of smoking cessation services (telephone
or face-to-face). Proactive outreach includes mailed invitation materials followed by an outreach call that
encourages smokers to seek treatment with choice of services. Proactive care participants who choose telephone
care receive VA telephone counseling and access to pharmacotherapy. Proactive care participants who choose
face-to-face care are referred to their VA facility’s smoking cessation clinic. Usual care participants have access to
standard smoking cessation services from their VA facility (e.g., pharmacotherapy, smoking cessation clinic) and
from their state telephone quitline. Baseline data is collected from VA administrative databases and participant
surveys. Outcomes from both groups are collected 12 months post-randomization from participant surveys and
from VA administrative databases. The primary outcome is self-reported smoking abstinence, which is assessed at
the population-level (i.e., among those who utilize and those who do not utilize tobacco treatment). Primary
analyses will follow intention-to-treat methodology.
Discussion: This randomized trial is testing proactive outreach strategies offering choice of smoking cessation
services, an innovation that if proven effective and cost-effective, will transform the way tobacco treatment is
delivered. National dissemination of proactive treatment strategies could dramatically reduce tobacco-related
morbidity, mortality, and health care costs.
Clinical trials registration: ClinicalTrials.gov: NCT00608426.
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Boosting utilization of evidence-based tobacco treat-
ments and eliminating tobacco-related health disparities
are top national tobacco control priorities [1]. Currently,
tobacco cessation treatment relies on reactive treatment
approaches that require smokers to either initiate treat-
ment or to have a clinical encounter in which the provi-
der has the time, initiative, and capacity to offer and
deliver smoking cessation care. As a result, the majority
of smokers do not receive evidence-based treatments (i.
e., pharmacotherapy and/or behavioral counseling) that
have demonstrated effectiveness for smoking cessation
[2-4].
The population impact of tobacco treatment relies on
exposure to treatment and is defined as the product of
the rate of utilization of treatment (i.e., reach) and the
efficacy of treatment (i.e., increase in smoking absti-
nence rates among those who utilize treatment) [2]. For
example, a smoking cessation program may result in a
50% increase in quit rates among those utilizing the pro-
gram but if only 2% of smokers utilize the program, the
population impact would be 1%. Effective treatments, if
rarely utilized, have negligible population impact; there-
fore, it is critical to maximize the reach of treatment.
In contrast to the two prevailing types of approaches
which consist largely of either intensive individual-level
intervention or traditional population-based interven-
tion, a proactive-population-based approach combines
the two and reaches out to all smokers in a given setting
(for example, smokers in a large health care system)
irrespective of level of motivation. Proactive treatment
approaches have great potential to integrate individual
and population-based perspectives and increase the
population impact of tobacco cessation treatment by
increasing the utilization of treatment with higher effec-
tiveness. Despite their great potential to increase reach
of more effective treatment, to date, there has been lim-
ited use of proactive treatment approaches for tobacco
cessation.
In this paper, we describe the study design and meth-
ods of a prospective randomized controlled trial to
determine the effects of a theory-driven intervention
combining 1) proactive outreach with 2) choice of tele-
phone care or face-to-face care for treatment of tobacco
dependence (proactive care) compared to reactive care
(usual care). This study overcomes prior limitations,
namely the ability to identify populations of smokers in
a health care system using the electronic medical record
and the availability of telephone care that can be used
to efficiently deliver intensive behavioral counseling and
pharmacotherapy. The specific aims of this trial are to:
1) assess the effects of proactive care on population-
level smoking abstinence rates and utilization of tobacco
treatment compared to usual care among a diverse
population of smokers who are enrolled in the Veterans
Health Administration (VHA), the nation’sl a r g e s ti n t e -
grated health care system, 2) compare the effects of
proactive care on population-level smoking abstinence
rates and utilization of tobacco treatment between Afri-
can American and White smokers, and 3) determine the
cost-effectiveness of the proactive care intervention.
Methods/design
Study design overview
This study is funded by the Department of Veterans
Affairs (VA) Health Services Research and Development
(HSR&D) and is registered in clinicaltrials.gov
(NCT00608426). The Veterans Victory over Tobacco
Study is a randomized controlled trial that compares the
effects of a proactive care intervention including proac-
tive outreach and choice of telephone care or face-to-
face care for tobacco dependence treatment compared
to reactive care (usual care). This study considers the
population impact of smoking cessation treatment.
Therefore, all smokers are included regardless of their
interest in quitting. The study design (Figure 1) is a
complete block design with subsampling in which 1600
individuals from each of four study sites are randomized
to one of two groups (total N = 6400). Hence, each site
constitutes a block and within each block 800 are
assigned to the intervention group and 800 are assigned
to usual care. Blocking by site controls for variation in
outcomes due to differences between sites such as
Figure 1 Study Design and Overview.
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factors. The VA’s electronic medical record (EMR)
Health Factors Dataset is used to identify current smo-
kers at the four study sites [4] and all smokers identified
are randomized prior to contact. Baseline data is
o b t a i n e df r o mV Aa d m i n i s t r a tive databases and from a
participant survey that is conducted immediately after
randomization. Outcome data is being collected 12
months after randomization from VA administrative
databases and from a follow-up survey.
Study sites
This study is being conducted at four VA medical cen-
ters: the James A. Haley VA Medical Center (Tampa
Bay, FL), the New York Harbor VA Medical Center
(Manhattan, NY), the G.V. (Sonny) Montgomery VA
Medical Center (Jackson, MS), and the Minneapolis VA
Medical Center (Minneapolis, MN). This study received
ethical approval from the institutional review boards of
the Minneapolis VA Medical Center (FWA00001480),
the New York Harbor VA Medical Center
(FWA00001881), the G.V. Montgomery VA Medical
Center (FWA00001598) and the University of Southern
Florida (FWA00001669).
Study participants
The sampling population for this study includes all
Veterans ages 18 and older who are identified as current
smokers from the VA’s EMR Health Factors Dataset at
each participating site. There are minimal exclusion cri-
teria to maximize generalizability to the VA primary
care population. However, any patient with an ICD9
diagnosis of dementia (i.e., 290.XX or 331.XX) or greater
than 10 mental health clinic visits in the past year,
determined from VA administrative data, is ineligible
for study participation.
Sampling procedures and strategy
The EMR Health Factors data are collected nationally
using a clinical reminder process, which consists of
automated requirements that providers must complete.
The VA EMR tobacco use clinical reminder is primar-
ily implemented in VA primary care clinics and infor-
mation is stored in the Health Factors tables within
the VA EMR databases [5]. The Health Factors tables
are used to generate a list of Veterans at each partici-
pating facility who are identified as current smokers
during a VA primary care visit in the past 3 months.
Data extractions are run at each site every 3 months
until the desired sample size at a given site for the two
groups is accrued. A 3-month interval was chosen to
ensure that we would have participants’ most recent
contact information.
Intervention group: reactive/usual care
The usual care group receives access to tobacco treat-
ment services from their local VA facility. Current VA
national guidelines mandate screening for tobacco use
and advising tobacco users to quit (i.e., brief counseling)
and facilities are held accountable for their rates of
screening and advice using performance measures,
which are based on external audit of medical records.
Treatment may be provided through primary care
clinics and/or specialty tobacco treatment clinics. In
addition, it is possible that participants may access help
to quit smoking by calling their state quitline or the
national quitline (1800QUITNOW). Treatment delivered
by primary care providers may consist of brief counsel-
ing to quit and medication treatment. Pharmacotherapy
is available in the form of nicotine patches, nicotine
gum or bupropion. Medication costs in the VA are sub-
s i d i z e da n dm a yb ef r e eo ran o m i n a lc o - p a yo f$ 9p e r
prescription is charged to Veteran depending upon their
eligibility status. Participants may also be referred to a
smoking cessation clinic from which they receive inten-
sive counseling, which consists of behavioral and cogni-
tive strategies to quit smoking. Behavioral counseling
usually occurs in a group setting and participants are
encouraged to attend at least 4 sessions, lasting 30-60
minutes, which are held once or twice per week. In
addition, a limited amount of individual counseling is
available. In sum, the cessation programs available at
these 4 sites are representative of existing programs
elsewhere in the VA and are comparable as to the avail-
ability of pharmacotherapy and face-to-face services.
Intervention group: proactive care
The theory-driven proactive care intervention combines
two main components: 1) proactive outreach (mailed
invitation materials followed by telephone outreach) and
2) offer of choice of smoking cessation services (tele-
phone care or face-to-face care), described below. Proac-
tive outreach is coordinated by trained counselors at the
Minneapolis VA Medical Center. Counselors have a BS
or MS level degree in a health related field and received
training in motivational interviewing and smoking cessa-
tion counseling from the California Smoker’sH e l p l i n e
and the study investigators. In addition to offering care,
the mailed materials (invitation letter and brochure) and
the proactive outreach call provides motivational
enhancement to encourage participants to quit smoking
and seek tobacco treatment. Participants who chose tel-
ephone care receive telephone counseling and care coor-
dination from counselors at the Minneapolis VA. For
proactive care participants who chose face-to-face care,
the counselors arrange a referral to their local VA facil-
ity’s smoking cessation program.
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The intervention is based on Social Cognitive Theory
(SCT) and the Stages of Change Model because choos-
ing to utilize treatment and ultimately to quit is affected
by a complicated web of both social and cognitive fac-
tors. SCT posits that cognitive processes largely regulate
behavior and points to the importance of both cognitive
(personal) and social environmental factors in determin-
ing behavior, which is highly relevant for tobacco cessa-
tion [6]. In addition, the intervention incorporates the
Stages of Change model, which posits behavioral change
occurs by moving along five distinct stages (precontem-
plation, contemplation, preparation, action and mainte-
nance) [7]. Proactive care through the invitation letter
and brochure, outreach call and telephone care cessation
services is expected to largely address provider and psy-
chosocial barriers to initiating care. The intervention
eliminates provider barriers both by directly offering
care and by providing the option of receiving such care
in the convenience of their home over the phone. The
intervention supplements provider treatment and does
not preclude the patient from participating in services
offered by the provider.
The intervention is expected to overcome psychosocial
barriers through the following three mechanisms. First,
motivational interviewing (MI) counseling is directed
towards increasing both motivation to quit and self-effi-
cacy as well as addressing environmental factors, such
as social network norms. MI is a patient-centered coun-
seling method whose main purpose is to help the parti-
cipant explore and resolve ambivalence about a
particular behavior change [8]. MI is an appropriate
intervention for smokers at all levels of readiness to quit
and entails asking the participant to talk about the pros
and cons of the behavior and how the behavior fits in
with his/her values and plans for the future. Important
features of MI are an emphasis on collaboration with
the participant, respect for his/her autonomy, and a goal
of understanding the participant’s point of view. The
counselor avoids confrontation and takes advantage of
many opportunities to enhance self-efficacy by pointing
out and reinforcing patient strengths and successes.
Recommendations for action are presented in the form
of menus (i.e., the participant is provided choices).
Second, the intervention reduces barriers for smokers
who have had or anticipate having negative medical care
experiences and/or mistrust medical care by offering a
program that does not require a medical care encounter.
In addition, since MI is collaborative in nature, the ther-
apeutic relationship is more like a partnership or com-
panionship than expert/recipient roles. This process is
expected to reduce fears of poor treatment, disrespect,
or discomfort associated with being the lowest status
person in an encounter.
Third, the invitation letter and the telephone counse-
lors address the safety, efficacy, and functional benefits
of pharmacotherapy. This is important because many
smokers are misinformed and are unaware that pharma-
cotherapy can help alleviate withdrawal symptoms that
have hindered their past cessation attempts [9,10].
Moreover, there is evidence that increasing knowledge
about safety and efficacy increases rates of smokers’ will-
ingness to use pharmacotherapy [10], potentially
increasing utilization rates.
Mailed invitation materials
Participants in the proactive care intervention group
receive a personalized invitation letter and a brochure
about the program. This invitation packet also contains
a refrigerator magnet that includes the study logo and
name, a toll-free phone number, and a statement, “You
can quit. VA coaches can help.” The letter and brochure
describe the types of tobacco treatment services avail-
able from the VA to quit smoking, and to help them
access treatment, offers the choice of telephone or face-
to-face services. In addition, because targeted health
communication messages that are specifically designed
to be relevant for a particular subgroup have been effec-
tive at increasing smoking [11] as well as in changing
other health-related behaviors, the letter includes tar-
geted messages aimed at motivating smokers to seek
treatment to quit smoking. These targeted messages
were based on information gleaned from focus groups
conducted with Veteran smokers. For example, the let-
ter includes information addressing several barriers to
minority and Veterans smokers’ use of such as the lack
of knowledge about the safety, efficacy and functional
benefits of pharmacotherapy. The letter also addresses
Veterans who are not ready to quit right now but who
want more information about treatment options and
“products that make it easier for smokers to quit.”
Telephone outreach
Ten days after the mailed invitation packet is sent (or
earlier for participants who respond to the letter), parti-
cipants receive an outreach call from a counselor trained
in motivational interviewing and smoking cessation
treatment. Up to 6 contact attempts over a two week
period are made at different times (i.e., morning, after-
noon, evening) during the day. The purpose of the out-
reach call is to 1) describe the VA smoking cessation
services available, 2) deliver motivational advice to quit
smoking, and 3) encourage participants to participate in
smoking cessation treatment.
Telephone care
Telephone care in this study combines proactive phone-
based counseling with increased access to pharmacologi-
cal therapy. The telephone care protocol is based on the
TELESTOP study which demonstrated the benefits of
telephone care compared to routine health care provider
Fu et al. BMC Public Health 2012, 12:159
http://www.biomedcentral.com/1471-2458/12/159
Page 4 of 9intervention for smoking cessation [12]. The TELESTOP
protocol is an adaptation for Veterans of the evidence-
based California Helpline protocol and uses a combina-
tion of motivational interviewing and cognitive-beha-
vioral treatment for substance abuse [13]. Telephone
counseling consists of 7 calls initiated by the counselor,
scheduled in a manner to minimize the likelihood of
relapse over a 2-month period (pre-quit, quit day, then
3 days, 1 week, 2 weeks, 1 months, and 2 months after
the quit date). In the pre-quit session, a major portion
of the counseling is spent promoting smokers’ self-effi-
cacy using motivational interviewing. Smokers are asked
to identify situations in which it would be most difficult
to refrain from smoking and to plan realistic coping
strategies. During the follow-up calls, the emphasis is on
successful implementation of effective coping strategies
and relapse prevention. Participants who relapse during
the program are encouraged to set new quit dates and
are able to repeat the counseling protocol.
Consistent with national smoking cessation guidelines,
counseling includes encouragement to use pharma-
cotherapy. The nicotine patch is recommended as the
initial agent. Other forms of NRT (e.g., gum, lozenge),
bupropion, or combinations of medications are recom-
mended if the subjects have prior unsuccessful quit
attempts using nicotine patch. Varenicline is considered
second-line therapy in the VHA. Counselors facilitate
access to pharmacotherapy by communicating with the
participant’s VHA primary care provider and/or smok-
ing cessation clinician(s) at the local VHA facility. Tele-
phone counselors enter an electronic progress note into
the EMR to document the telephone counseling and the
participant’s preference for pharmacotherapy and desig-
nate the primary care provider and/or the smoking ces-
sation clinician(s) as additional signers on the progress
notes. The participant’s VA providers are responsible for
prescribing the smoking cessation medications as part of
their routine clinical practice.
Face to face care
Face-to-face smoking cessation programs represent the
standard of care for delivery of smoking cessation care
in the VHA. For proactive care participants who chose
face-to-face care, the counselors arrange a referral to
their local VHA facility’s smoking cessation clinic.
Proactive care participants who chose face-to-face care
receive the same care as usual care participants who are
referred by their VHA provider.
Data collection
Data collection occurs at baseline (i.e., at time of rando-
mization) and at 12 months post-randomization. Data
sources include survey data collected at baseline and at
the twelve month follow up assessment, and VA admin-
istrative databases. Both the baseline survey and follow-
up survey are 8-pages and are estimated to take the
average participant 15 minutes to complete. The base-
line survey consists of 79 questions and the follow-up
survey includes 83 questions. The baseline survey mail-
ing follows a modified Dillman protocol to maximize
response rates and data quality (mail + postcard remin-
der + mail + mail) [14]. The 1
st survey mailing includes
a cover letter describing the study, a $10 cash incentive,
the self-administered survey instrument, a postage paid
return envelope, and an informed consent statement
describing the study. Approximately 10 days later, a
reminder postcard is mailed to non-respondents. About
two to three weeks after the postcard is mailed, a 2
nd
survey, cover letter, pen, and postage paid return envel-
ope is mailed to all participants who have not yet
returned a survey. About two to three weeks after the
2
nd survey mailing, participants who do not return a
mailed survey are mailed a shortened, 2-page survey,
cover letter, and a postage paid return envelope.
The 12-month follow-up survey also follows a modi-
fied Dillman protocol. First, participants are sent a pre-
letter explaining that they will be receiving a survey in
the mail within a few days. A few days after the pre-let-
ter, participants are mailed a survey. This mailing
includes a cover letter, a $10 cash incentive, the follow-
up survey, and a postage paid return envelope. A remin-
der post-card is mailed to non-respondents about 10
days after the 1st survey mailing. About two weeks later,
non-respondents are mailed a second survey along with
a cover letter, a pen, and a postage paid return envelope.
Approximately two weeks later, anyone who has not
responded to the survey is randomized to one of two
methods of contact for the fifth and final contact: 1)
mailed a shortened, 2-page follow-up survey via USPS
first class mail along with a cover letter and a postage
paid return envelope, or 2) telephone administration of
the shortened, follow-up survey. Up to six telephone
contact attempts are made at various times of the day.
There are several reasons for the experiment. The first
reason is to see if the additional cost of a telephone fol-
low-up is an efficient method for increasing response
rates. Also, there is movement toward surveys that use
more than one mode of data collection, but it is not
clear if it is the additional attempts that increase
response rate, or the change in mode. This experiment
will allow us to examine if changing the mode for a
final attempt increases response rates, or if the mode of
the final contact does not matter.
Outcome measures
The primary outcome is self-reported smoking absti-
nence of 6 months duration, irrespective of treatment
utilization (i.e., smoking abstinence among all smokers
including those who use and those who do not use
Fu et al. BMC Public Health 2012, 12:159
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the follow-up survey 12 months after randomization.
Following the Society for Research on Nicotine and
Tobacco (SRNT) Measures Workgroup Recommenda-
tions, the primary outcome is defined as having not
smoked at least part of a cigarette on each of 7 consecu-
tive days and having not smoked at least once on a
weekend day over 2 consecutive weekends in the past 6
months [15]. Secondary measures of abstinence include
self-reported 7-day point pr e v a l e n c ea n d3 0 - d a yp o i n t
prevalence, defined as having not smoked a part of a
cigarette in the past 7 days and as having not smoked a
part of a cigarette in the past 30 days, respectively.
Other outcomes for this study comprise utilization
and initiation of tobacco cessation treatment (from any
source, including supplemental care from outside the
VA) during the 12 month follow-up, specifically: 1)
initiation of combined intensive behavioral counseling
and medication treatment, 2) initiation of intensive
behavioral counseling, and 3) initiation of medication
treatment. Since some smokers may seek treatment
from non-VA providers due to the proactive strategies
tested, the secondary outcomes are primarily assessed
using self-report from the 12-month follow-up survey.
Initiation of medication treatment is defined as using
one or more tobacco dependence medications (e.g.,
NRT and bupropion) in the 12-month follow-up period
(from any source, VA and non-VA). Initiation of inten-
sive counseling is defined as the completion of at least
one call from a telephone counseling program or mak-
ing at least one visit to a smoking cessation program in
the 12-month follow-up period (from any source, VA
and non-VA). In addition, we are assessing VA tobacco
treatment utilization using VA administrative data–
pharmacy dispensing records and visits to smoking ces-
sation clinics
Potential moderators and confounders
Background factors
The following patient demographics are assessed in the
survey: race, ethnicity, marital status, education, annual
household income, and employment status. Alcohol
consumption is assessed using the AUDIT-C [16]. VA
administrative data sources are used to provide informa-
tion on age, sex, and co-morbid conditions (e.g., ICD-9
codes).
Smoking behavior
Information regarding smoking history such as age of
initiation, duration of smoking, previous quit attempts
and prior use of tobacco treatment is collected using
standard questions from the California Tobacco Survey
[17] and the CDC Behavioral Risk Factor Surveillance
Survey [18]. Nicotine dependence is assessed with the
two-question Heaviness of Smoking Index: cigarettes
per day and time to first cigarette after waking [19].
Potential mediators
Provider factors
The provider factors examined include provider beha-
vior related to delivery of smoking cessation care and
communication style. Standard tobacco performance
measures assess participants’ receipt of smoking cessa-
tion advice, counseling and treatment from their VA
primary care provider [20]. Questions from the Com-
monwealth Fund Survey are used to assess provider
communication [21].
Cognitive factors
The cognitive factors examined in this study include
motivation to quit, self-efficacy, attitudes toward NRT,
mastery, and smoking stigma. Self-efficacy to quit and
motivation to quit are assessed with a global measure of
self-efficacy to quit [22], three self-efficacy subscales
(situational self-efficacy which includes emotional and
social self-efficacy and skill self-efficacy) [23] and the
readiness to quit ladder [24,25]. Beliefs towards smoking
cessation medications is assessed using the 12-item atti-
tudes towards nicotine replacement therapy scale
(ANRT-12) [26]. Mastery is measured using a standard
7-item questionnaire assessing the control one feels over
one’s life [27]. Smoking stigma, the concept that one
feels stigmatized due to their smoking behavior, has
been adapted from the Mental Health Consumers’
Experience of Stigma [28].
Discrimination
In this study discrimination in the health care setting is
assessed using the Physician Bias and Interpersonal Cul-
tural Competence Measures Scale [21] which consists of
3 questions asking about being treated with respect by
the doctor, the doctor’s understanding of the participant’s
background and values, and feeling like the doctor looks
down on the participant’s way of life. Health care discri-
mination is also measured with a general question asking
if the patient feels they have been discriminated against
in a health care situation for any reason [29]. Day to day
perceived discrimination is measured using nine ques-
tions that ask about the frequency of exposure to experi-
ences of discrimination such as being treated with less
courtesy, less respect, or being harassed [30].
Social environment
Participants’ self-report their level of satisfaction with
smoking cessation care from the VA on the follow-up
survey [31]. Characteristics of the environment that
make it difficult for them to participate in smoking ces-
sation care from the VA are also being assessed (e.g.,
lack of transportation, and distance to site) [13]. Charac-
teristics of the patient’s social network assessed in the
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smoking habits of friends and family, and home smoking
rules.
Analytic overview
With our proposed sample size (3200 per intervention
group), random assignment can be expected to create
two groups that are balanced with respect to observed
and unobserved baseline characteristics. However, due
to possible differential non-response among the two
groups this balance may be missing between survey
respondents within the two groups. To assess such
imbalance, the respondents in the two groups will be
compared with respect to key elements of the concep-
tual model and baseline measures a priori known to be
related to smoking cessation and treatment utilization.
Balance of the two groups will be tested using Mantel-
Haenszel c
2 tests for categorical variables which
accounts for stratification by site and appropriate para-
metric tests (e.g. Blocked Anova F-tests) or nonpara-
metric tests (e.g. Wilcoxon rank-sum test) for
continuous variables. If the two groups are found to dif-
fer with respect to these relevant pre-intervention vari-
ables, then these variables will be included as covariates
in the following analyses. These analyses and related
comparisons of responders and non-responders will
shed light on potential response bias issues. A usual
practice in is to treat non-respondents at follow-up as
continuing smokers. This practice is considered to be a
conservative assumption; however, if usual care has sig-
nificantly lower response rates to the follow-up survey
than proactive care then this approach would favor the
intervention. To address potential response bias issues,
we will use standard statistical methodologies and
implement propensity-based and imputation methods
with imputation of smoking status or treatment utiliza-
tion at follow-up. For VA treatment utilization out-
comes, non-response is not an issue because we will
obtain information from VA administrative databases on
all randomized individuals.
The primary analysis will be by intention-to-treat.
Since population-level smoking abstinence rates are
expected to be small, z-tests comparing the strata-
weighted differences between the two groups are less
appropriate than comparisons based on odds ratios. The
study design is a randomized complete block design,
however, the patient populations within site vary and
hence the proportion of the site population included in
the study varies across site. Different intra-block (strati-
fied) logistic analyses have been devised for similar sur-
vey designs for sampling from finite populations [32,33].
Herein these survey design-based logistic analyses are
referred to as survey-logistic regressions. We will use
survey-logistic regression methods to estimate and test
intervention effects and racial/ethnic differences in the
intervention effects on both smoking abstinence (e.g., 6-
month prolonged abstinence, 7-day and 30-day point
prevalence abstinence) and treatment utilization rates.
These regression models will take into account the
design stratification and the relative stratification popu-
lations. The models also will include any relevant cov-
ariates to adjust for confounding, if warranted. In this
event we will use cross validation methods and standard
model diagnostic methods to identify a well fitting
model. Inference with respect to the impact of the inter-
vention will be based on point estimates of the odds
ratio for the effect of proactive outreach on the outcome
relative to usual care, along with 95% confidence inter-
vals and corresponding standard test results.
Sample size and power analysis
The power analysis assumes independent samples in the
two groups from the four sites and considers a type one
error rate of 0.05. A meaningful difference, from a pub-
lic health perspective, is for PRO to produce a 2%
increase in population-level smoking abstinence rates
compared to UC. Using a base rate of 3% to estimate
the sample size for this study, this study requires 1500
participants per intervention group (or total N = 3000)
to have at least 80% power to detect a 2% or greater
absolute difference in population-level smoking absti-
nence rates between groups. In addition, this study is
well powered (> 90%) to detect clinically meaningful dif-
ferences of 6% in treatment utilization rates using the
most conservative base rate assumption of 50%. In order
to achieve 3000 completed follow-up surveys from parti-
cipants, we estimated that we need to include 6400 par-
ticipants who will be sent the baseline survey. Among
the 6400 participants who are mailed a baseline survey,
we estimate approximately 5120 participants (20% exclu-
sion rate due to subject refusal and misclassification of
cigarette smoking status) will be sent a follow-up survey.
We estimate a 60% response rate to the follow-up sur-
vey, which will result in about 3000 completed follow-
up surveys.
Discussion
In general, population-based interventions lead to higher
utilization rates but may have lower efficacy because
they are less intensive (e.g., mass mailings of self-help
materials) whereas individual-level interventions might
have higher efficacy but lower utilization rates. Intensive
individual-level interventions include clinic-based treat-
ment and generally involve reactively recruited smokers
(i.e. individuals who are ready to quit and seek out assis-
tance). While clinic-based treatments yield high long-
term quit rates, on the order of 20-30%, they are also
known to have the low utilization rates [34]. For
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nizations use the state-of-the science smoking cessation
clinics the systems offer [2,35,36]. In spite of national
guidelines, only about 1 in 3 smokers who visited a
health care provider in the past year used a tobacco
dependence treatment during a quit attempt [4]. Over
70% of smokers say they want to quit, leaving a huge
gap between interest in quitting and use of treatment
services [34].
The Veterans Victory Over Tobacco Project bridges
individual and population-based perspectives to increase
the population impact of tobacco treatment by increas-
ing utilization of more effective programs. The proactive
care intervention evaluated in this study is hypothesized
to have a greater population impact because it combines
strategies that can 1) achieve wide reach and increase
utilization of treatment (proactive outreach), and 2)
increase the effectiveness of treatment by efficiently deli-
vering intensive behavioral and pharmacologic treat-
ments (option of telephone care).
Previously, proactive treatment approaches have been
limited by the inability to efficiently identify current
smokers in the general population and by the reliance
on in-person smoking cessation counseling. One barrier
to the use of proactive treatment approaches is difficulty
identifying current smokers in the general population. A
second issue involves the availability of an intervention
that is both effective and feasible to administer using a
proactive approach. Interventions that have taken a
proactive, population-based approach usually have deliv-
ered less intensive interventions such as mailings of self-
help quitting manuals [37,38]. However, a few recent
studies have capitalized on the availability of validated
telephone counseling protocols to provide intensive
behavioral counseling with pharmacotherapy [39,40] on
a large-scale, in a way that would be feasible for a
proactive treatment approach.
For example, two studies identified smokers using
pharmacy databases from large health plans, based on
tracking individuals who had recently filled a prescrip-
tion for a tobacco dependence medication. To offer tele-
phone counseling as an adjunct to pharmacotherapy,
smokers in the first study received proactive outreach
which involved a mailed letter and a telephone call.
Proactive outreach resulted in 31% (205/663) of smokers
utilizing telephone counseling [39]. Similarly, in the sec-
ond study, a proactive phone call (no letter) resulted in
21% of smokers utilizing telephone counseling [40]. In
addition, a community survey assessed adult smokers’
response to direct telemarketing of smoking cessation
interventions and found that almost half would utilize a
“we-call-you” telephone counseling service [41]. The
proposed study extends this research because all smo-
kers are being identified from the electronic medical
record, not just those smokers who have already
received pharmacologic treatment, and the proactive
care interventions offers a choice of telephone or face-
to-face smoking cessation services.
The strength of this project is the use of a population-
based approach to evaluate the effectiveness of proactive
outreach and choice of care on population-level quit
rates. All smokers, regardless of motivational level to
quit smoking are included, and therefore, findings will
have greater generalizability than traditional clinical
trials. However, the intervention combines two main
components (proactive outreach and the option of tele-
phone care); therefore, if it has a positive effect on
population-level smoking abstinence rates, it will be dif-
ficult to determine which component(s) are responsible.
However, the intervention components integrate indivi-
dual and population-based approaches and so are
important to evaluate together.
In conclusion, this study is significant because it has
the potential to transform and improve the effectiveness
of the delivery of tobacco treatment. National guidelines
have made it a priority to increase access to tobacco
treatment as part of a population-based approach to
tobacco cessation [3]. If proven to be effective and
acceptably low-cost, national dissemination of proactive
treatment approaches would have potential to dramati-
cally reduce tobacco-related morbidity, mortality, and
health care costs for the nation.
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